Drugs / DTG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04076423 Comparator | Oct 2019 → Jun 2023 | HIV infectious disease | Fundacion SEIMC-GESIDA | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTG | “DTG + 3TC” NCT04076423 ↗ |
| Route | Oral | “50 mg of DTG orally, once a day” NCT04076423 ↗ |